LOADING
Comparing Thermo Fisher Scientific (TMO) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | TMO | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $212.7B | $169.0B |
| P/E Ratio | 31.1 | 8.1 |
| Forward P/E | 23.0 | 10.5 |
| PEG Ratio | 1.88 | 1.63 |
| EPS | $18.56 | $3.06 |
| Revenue Growth (YoY) | 10.5% | 2.3% |
| Profit Margin | 15.0% | 16.9% |
| Return on Equity | 13.5% | 18.3% |
| Dividend Yield | 0.15% | 4.55% |
| Beta | 0.87 | 0.42 |
| 52-Week High | $642.71 | $28.75 |
| 52-Week Low | $434.83 | $19.63 |
| Volume | -- | -- |
Thermo Fisher Scientific is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AT&T Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.